They provided evidence that heparanase preferently is expressed in clinical/experimental obesity-associated breast tumors, and that heparanase deficiency abolishes obesity-accelerated orthotopic tumor growth. The gene discussed is HPSE; the disease is obesity due to melanocortin 4 receptor deficiency.